In initial experiments, we tested the effect of several Ficz-related derivatives on the induction of IL-22 in activated IBD PBMC (Figure 1), as we previously showed that the anti-inflammatory properties of AhR rely mainly on the induction of such a cytokine (Monteleone et al., 2011). This evidence concerns the gene IL22 and inflammatory bowel disease.